Mostrar el registro sencillo del ítem

dc.contributor.authorLópez-Causapé, Carla
dc.contributor.authorSommer, Lea Mette
dc.contributor.authorCabot, Gabriel
dc.contributor.authorRubio, Rosa
dc.contributor.authorOcampo-Sosa, Alain A
dc.contributor.authorJohansen, Helle Krogh
dc.contributor.authorFiguerola Mulet, Joan
dc.contributor.authorCanton, Rafael
dc.contributor.authorKidd, Timothy J
dc.contributor.authorMolin, Soeren
dc.contributor.authorOliver, Antonio
dc.date.accessioned2024-07-11T09:10:38Z
dc.date.available2024-07-11T09:10:38Z
dc.date.issued2017-07-17
dc.identifier.citationLópez-Causapé C, Sommer LM, Cabot G, Rubio R, Ocampo-Sosa AA, Krogh Johansen H, et al. Evolution of the Pseudomonas aeruginosa mutational resistome in an international Cystic Fibrosis clone. Sci Rep. 2017 Jul 17;7:5555.en
dc.identifier.issn2045-2322
dc.identifier.otherhttp://hdl.handle.net/20.500.13003/9744
dc.identifier.urihttp://hdl.handle.net/20.500.12105/20443
dc.description.abstractEmergence of epidemic clones and antibiotic resistance development compromises the management of Pseudomonas aeruginosa cystic fibrosis (CF) chronic respiratory infections. Whole genome sequencing (WGS) was used to decipher the phylogeny, interpatient dissemination, WGS mutator genotypes (mutome) and resistome of a widespread clone (CC274), in isolates from two highly-distant countries, Australia and Spain, covering an 18-year period. The coexistence of two divergent CC274 clonal lineages was revealed, but without evident geographical barrier; phylogenetic reconstructions and mutational resistome demonstrated the interpatient transmission of mutators. The extraordinary capacity of P. aeruginosa to develop resistance was evidenced by the emergence of mutations in > 100 genes related to antibiotic resistance during the evolution of CC274, catalyzed by mutator phenotypes. While the presence of classical mutational resistance mechanisms was confirmed and correlated with resistance phenotypes, results also showed a major role of unexpected mutations. Among them, PBP3 mutations, shaping up beta-lactam resistance, were noteworthy. A high selective pressure for mexZ mutations was evidenced, but we showed for the first time that high-level aminoglycoside resistance in CF is likely driven by mutations in fusA1/fusA2, coding for elongation factor G. Altogether, our results provide valuable information for understanding the evolution of the mutational resistome of CF P. aeruginosa.en
dc.description.sponsorshipWe gratefully acknowledge the participants, associated staff (Women's and Children's Hospital, Adelaide; Royal Children's Hospital, Brisbane; Royal Children's Hospital, Melbourne; Mater Misericordiae Hospital, Brisbane; Children's Hospital at Westmead, Sydney, John Hunter Adult Hospital, Newcastle), Prof Scott Bell (QIMR Berghofer), Prof Claire Wainwright (The University of Queensland) and Prof Keith Grimwood (Griffith University) for their assistance with providing access to the Australian isolates used in this study. The contribution to this study of the Cystic Fibrosis Units from Hospital Ramon y Cajal and Hospital Son Espases is also acknowledged. This work was supported by the Ministerio de Economia y Competitividad of Spain, Instituto de Salud Carlos III, and was cofinanced by the European Regional Development Fund (ERDF) project A way to achieve Europe through the Spanish Network for Research in Infectious Diseases (REIPI) (RD12/0015 and RD16/0016) and grants PI15/00088. C.L.-C. received a fellowship from the Spanish Society of Microbiology and Infectious Diseases (SEIMC) and from the REIPI. T.J.K is a National Health and Medical Research Council Early Career Fellowship (GNT1088448).es_ES
dc.language.isoengen
dc.publisherNature Publishing Group en
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subject.meshbeta-Lactam Resistance *
dc.subject.meshAustralia *
dc.subject.meshSpain *
dc.subject.meshMicrobial Sensitivity Tests *
dc.subject.meshHumans *
dc.subject.meshPenicillin-Binding Proteins *
dc.subject.meshDrug Resistance, Bacterial *
dc.subject.meshCystic Fibrosis *
dc.subject.meshFluoroquinolones *
dc.subject.meshMutation *
dc.subject.meshPhylogeny *
dc.subject.meshPseudomonas aeruginosa *
dc.subject.meshPolymyxins *
dc.subject.meshPrevalence *
dc.titleEvolution of the Pseudomonas aeruginosa mutational resistome in an international Cystic Fibrosis cloneen
dc.typeresearch articleen
dc.rights.licenseAttribution 4.0 International*
dc.identifier.pubmedID28717172es_ES
dc.format.volume7es_ES
dc.format.page5555es_ES
dc.identifier.doi10.1038/s41598-017-05621-5
dc.relation.publisherversionhttps://dx.doi.org/10.1038/s41598-017-05621-5en
dc.identifier.journalScientific Reportses_ES
dc.rights.accessRightsopen accessen
dc.subject.decsProteínas de Unión a las Penicilinas*
dc.subject.decsPrevalencia*
dc.subject.decsFluoroquinolonas*
dc.subject.decsFarmacorresistencia Bacteriana*
dc.subject.decsMutación*
dc.subject.decsFilogenia*
dc.subject.decsFibrosis Quística*
dc.subject.decsPruebas de Sensibilidad Microbiana*
dc.subject.decsHumanos*
dc.subject.decsAustralia*
dc.subject.decsPolimixinas*
dc.subject.decsPseudomonas aeruginosa*
dc.subject.decsResistencia betalactámica*
dc.subject.decsEspaña*
dc.identifier.scopus2-s2.0-85025116852
dc.identifier.wos405675400035
dc.identifier.puiL625883985


Ficheros en el ítem

FicherosTamañoFormatoVer

No hay ficheros asociados a este ítem.

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Attribution 4.0 International
Este Item está sujeto a una licencia Creative Commons: Attribution 4.0 International